La Jolla Pharmaceutical Company - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsLa Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company(LJPC)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

hepatocellular carcinoma

,

liver neoplasms

,

neoplasm metastasis

Calcium dobesilate

,

lymphoid leukemia

,

precursor b-cell lymphoblastic leukemia-lymphoma

,

multiple myeloma

,

precursor cell lymphoblastic leukemia-lymphoma

,

,

,

acquired immunodeficiency syndrome

,

immune reconstitution inflammatory syndrome

healthy volunteers/patients

,

,

breast neoplasms

,

,

hyperaldosteronism

,

,

atrial fibrillation

gastrointestinal stromal tumors

,

,

iron-deficiency anemia

,

iron deficiencies

,

,

,

,

small cell lung carcinoma

,

healthy volunteers/patients

,

,

,

,

primary myelofibrosis

,

myeloid leukemia acute

,

myeloid leukemia

,

prostatic neoplasms

,

,

hepatocellular carcinoma

,

plexiform neurofibroma

,

neurofibromatoses

,

,

,

,

chronic obstructive pulmonary disease

,

,

,

triple negative breast neoplasms

,

,

,

essential thrombocythemia

,

polycythemia vera

,

,

,

lupus nephritis

,

inflammatory breast neoplasms

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

wiskott-aldrich syndrome

,

bcr-abl positive chronic myelogenous leukemia

,

,

hematopoietic stem cell transplantation

,

bronchiolitis obliterans syndrome

,

,

hyperlipoproteinemia type ii

,

graft vs host disease

,

organ transplantation

,

homozygous familial hypercholesterolemia

,

cryopyrin-associated periodic syndromes

,

,

psychology rejection

,

myelodysplastic syndromes

,

,

liver transplantation

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

parkinson disease

,

,

,

,

juvenile arthritis

,

,

,

hepatitis b virus

,

,

,

pituitary acth hypersecretion

,

,

acute coronary syndrome

,

,

myocardial infarction

,

coronary stenosis

,

atherosclerotic plaque

,

,

,

hypersensitivity

,

pulmonary eosinophilia

,

pancreatic neoplasms

,

,

,

kidney transplantation

,

,

hypercholesterolemia

,

atherosclerosis

,

breast neoplasms

,

,

hyperlipidemias

,

cardiovascular diseases

,

chronic kidney failure

,

kidney diseases

,

thrombocytopenia

,

,

,

coronary artery disease

,

,

,

chronic renal insufficiency

,

,

renal replacement therapy

,

renal insufficiency

,

drug-related side effects and adverse reactions

,

heart transplantation

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

cystic fibrosis

,

pseudomonas infections

,

type 2 diabetes mellitus

,

,

multiple myeloma

,

plasma cell neoplasms

,

transplantation

,

cytomegalovirus infections

,

communicable diseases

,

neoplasm metastasis

,

metabolic syndrome

,

preconception care

,

drug interactions

,

percutaneous coronary intervention

,

,

phenylketonurias

beta-thalassemia

,

,

polycythemia vera

,

Bos taurus adrenal cortex corticosteroids

ulcerative colitis

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use